Xalabrands Xalabrands [Member] Xalabrands Business Acquisition [Axis] Business Acquisition [Axis] Trade accounts payable Accounts Payable, Trade Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Deferred income tax benefit Deferred Income Tax Assets, Net Total Long-Term Debt, Gross Entity Address, Postal Zip Code Entity Address, Postal Zip Code Equity securities Debt Securities, Trading, and Equity Securities, FV-NI 2023 Long-Term Debt, Maturity, Year Two Valuation Technique, Discounted Cash Flow Valuation Technique, Discounted Cash Flow [Member] Debt Instrument [Axis] Debt Instrument [Axis] Property, plant and equipment, gross Property, Plant and Equipment, Gross 2023 Senior Notes (3.125% coupon) SeniorNotesTwoThousandTwentyThree3.125Percent [Member] Senior notes two thousand twenty three - 3.125 percent 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan [Member] 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Maximum Borrowing Capacity Receivable [Domain] Receivable [Domain] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Fair value of long-term debt Debt Instrument, Fair Value Disclosure Yupelri ® Yupelri ® [Member] Yupelri ® Beginning Balance Ending Balance Restructuring Reserve Prepaid Expense and Other Assets [Abstract] Prepaid Expense and Other Assets [Abstract] Foreign currency forward contracts Foreign Exchange Contract [Member] Fair Value of Financial Instruments Policy Fair Value of Financial Instruments, Policy [Policy Text Block] Additional paid-in capital Additional Paid in Capital Revenue of biosimilars portfolio Disposal Group, Including Discontinued Operation, Revenue Payments for product rights and other, net Payments for (Proceeds from) Other Investing Activities Income Tax Examination, Partial Payment Of Income Tax Expense Income Tax Examination, Partial Payment Of Income Tax Expense Income Tax Examination, Partial Payment Of Income Tax Expense Range [Domain] Statistical Measurement [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Accounts Payable, Current [Abstract] Accounts Payable, Current [Abstract] Short-term Debt, Type [Axis] Short-Term Debt, Type [Axis] Stated percentage rate Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate, Stated Percentage 2032 Euro Senior Notes 2032 Euro Senior Notes [Member] 2032 Euro Senior Notes Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Schedule of Business Acquisitions by Acquisition, Contingent Consideration Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Proceeds from the sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities 2043 Senior Notes (5.400% coupon) SeniorNotesTwoThousandFortyThree [Member] Senior notes two thousand forty three Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-Based Payment Arrangement [Abstract] Viagra ® Viagra ® [Member] Viagra ® Percent Of Total Assets Impacted, High Inflationary Economy Percent Of Total Assets Impacted, High Inflationary Economy Percent Of Total Assets Impacted, High Inflationary Economy Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Other non-cash items Other Noncash Income (Expense) Net unrecognized gain on derivatives in net investment hedging relationships, net of tax Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx Foreign exchange derivative liabilities Foreign Currency Contracts, Liability, Fair Value Disclosure Clean Energy Partnerships [Member] Clean energy investments Clean Energy Partnerships [Member] Clean Energy Partnerships Business Combination, Price of Acquisition, Expected Business Combination, Price of Acquisition, Expected Measurement Input Type [Domain] Measurement Input Type [Domain] Program Name [Axis] Program Name [Axis] Program Name Anti-dilutive stock options or restricted stock awards excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Available-for-sale fixed income investments Debt Securities [Member] Minimum Repayments on Outstanding Borrowings Schedule of Maturities of Long-Term Debt [Table Text Block] Subsequent Event Type [Axis] Subsequent Event Type [Axis] EpiPen® Auto-Injectors EpiPen® Auto-Injectors [Member] EpiPen® Auto-Injectors Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Net unrealized loss on marketable securities, net of tax AOCI, Debt Securities, Available-for-Sale, Adjustment, after Tax Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Scenario [Axis] Scenario [Axis] Total assets at recurring fair value measurement Assets, Fair Value Disclosure Restructuring Plan [Axis] Restructuring Plan [Axis] North America Segment North America Segment [Member] North America Segment Investment, Name [Domain] Investment, Name [Domain] Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Payments of financing fees Payments of Financing Costs Additional cash payments to be received Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration Arrangements, Range Of Outcomes, High Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration Arrangements, Range Of Outcomes, High Foreign currency translation adjustment Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Plan Name [Axis] Plan Name [Axis] Business Acquisition, Share Price Business Acquisition, Share Price Net unrecognized gain and prior service cost related to defined benefit plans, net of tax Net unrecognized losses and prior service cost related to defined benefit plans, net of tax Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Available-for-sale securities Debt Securities, Available-for-Sale Hedging Designation [Domain] Hedging Designation [Domain] Derivative Instruments Risk [Axis] Derivative Instrument Risk [Axis] Derivative Instrument [Axis] Forfeited Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Plan Name [Domain] Plan Name [Domain] Goodwill [Line Items] Goodwill [Line Items] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Long-term Line of Credit Long-Term Line of Credit Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 [Member] 2020 Euro Senior Notes 2020 Euro Senior Notes [Member] 2020 Euro Senior Notes [Member] Average remaining contractual term for stock awards outstanding, in years Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Award Type [Axis] Award Type [Axis] Recognized net actuarial losses Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Change in unrecognized (loss) gain and prior service cost related to defined benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Operating lease liability Operating Lease, Liability, Current Revenue Recognition And Accounts Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Nonvested Restricted Stock and Restricted Stock Unit Awards Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Adjustments to reconcile net earnings (loss) to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Measurement Input, Estimated Tax Rate Measurement Input, Estimated Tax Rate [Member] Measurement Input, Estimated Tax Rate [Member] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Estimated employer contributions in current year Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year Legal Entity [Axis] Legal Entity [Axis] Liability Class [Axis] Liability Class [Axis] Long-term debt Long-term Debt, Excluding Current Maturities Long-Term Debt, Excluding Current Maturities Revenue Recognition and Deferred Revenue [Abstract] Revenue Recognition and Deferred Revenue [Abstract] 2020 Restructuring Plan 2020 Restructuring Plan [Member] 2020 Restructuring Plan Total liabilities Liabilities Reporting Unit, Amount of Fair Value in Excess of Carrying Amount Reporting Unit, Amount of Fair Value in Excess of Carrying Amount Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Geographical [Axis] Geographical [Axis] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Business Acquisition, Percentage of Voting Interests Acquired Business Acquisition, Percentage of Voting Interests Acquired Issuance of common stock Stock Issued During Period, Value, New Issues Goodwill Impairment, Measurement Input, Term Goodwill Impairment, Measurement Input, Term Goodwill Impairment, Measurement Input, Term Accounting Changes and Error Corrections [Abstract] Accounting Changes and Error Corrections [Abstract] Entity Ordinary Shares, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Other Current Portion of Long-term Debt Other Current Portion of Long-term Debt [Member] Other Current Portion of Long-term Debt [Member] Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Gains and Losses on Marketable Securities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] Document Type Document Type Weighted Average Exercise Price per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Restructuring Type [Axis] Restructuring Type [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Measurement Input, Terminal Year Revenue Growth Rate Measurement Input, Terminal Year Revenue Growth Rate [Member] Measurement Input, Terminal Year Revenue Growth Rate Weighted average grant-date fair value per share, nonvested beginning of period Weighted average grant-date fair value per share, nonvested end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Segments [Axis] Segments [Axis] Debt Debt Disclosure [Text Block] Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Deferred income tax (benefit) expense Deferred Income Tax Expense (Benefit) Number of cases Number of cases Number of cases Consolidated Entity Consolidated Entity, Excluding VIE [Member] JANZ Japan, Australia and New Zealand Segment [Member] Japan, Australia and New Zealand Segment Inventories Disposal Group, Including Discontinued Operation, Inventory, Current Goodwill Disposal Group, Including Discontinued Operation, Goodwill Famy Life Sciences Private Limited Famy Life Sciences Private Limited [Member] Famy Life Sciences Private Limited Intellectual Property Developed Technology Rights [Member] Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] 2024 Long-Term Debt, Maturity, Year Three Net unrecognized gain on derivatives in cash flow hedging relationships Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Gain (Loss) on Fair Value Hedges Recognized in Earnings Gain (Loss) on Fair Value Hedges Recognized in Earnings Financial Instruments and Risk Management Financial Instruments Disclosure [Text Block] Subsequent Event Subsequent Event [Member] Consolidation Items [Domain] Consolidation Items [Domain] Document Period End Date Document Period End Date Schedule of Cash, cash equivalents, and restricted cash Schedule of Cash, Cash Equivalents and Restricted Cash [Table Text Block] [Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table] Unusual or Infrequent Item, or Both [Axis] Unusual or Infrequent Item, or Both [Axis] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Amortization of prior service costs Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Total assets Assets Debt Disclosure [Abstract] Debt Disclosure [Abstract] Earnings (loss) per share attributable to Viatris Inc. shareholders Earnings Per Share [Abstract] Earnings Per Share [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Interest rate swaps Interest Rate Swap [Member] Accounts payable Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Balance (in shares) Balance (in shares) Shares, Issued Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Current portion of long-term debt and other long-term obligations Long-Term Debt, Current Maturities Restructuring Reserve, Noncurrent Restructuring Reserve, Noncurrent Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities 2048 Senior Notes (5.200%) SeniorNotesTwoThousandFortyEight [Member] SeniorNotesTwoThousandFortyEight [Member] Share repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Number of equity method investments Number of equity method investments Number of equity method investments Payroll and employee benefit liabilities Employee-related Liabilities, Current Line of Credit [Member] Line of Credit [Member] Asset-backed Securities Asset-Backed Securities [Member] 2.125% Euro Senior Notes due 2025 2025 Euro Senior Notes [Member] 2025 Euro Senior Notes [Member] Viatris Inc. shareholders’ equity Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Earnings before income taxes Operating and non-operating expense Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Segments [Domain] Segments [Domain] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Business Acquisition, Contingent Consideration Per Share Business Acquisition, Contingent Consideration Per Share Business Acquisition, Contingent Consideration Per Share 2026 Senior Notes (3.950% coupon) SeniorNotesTwoThousandTwentySix3.95Precent [Member] 2026 Senior Notes 3.950% Intangible assets, net Disposal Group, Including Discontinued Operation, Intangible Assets Earnings (Loss) per Ordinary Share Earnings Per Share [Text Block] Other Liabilities, Current [Abstract] Other Liabilities, Current [Abstract] Other long-term obligations Other Noncurrent Liabilities [Member] Interest cost Defined Benefit Plan, Interest Cost Goodwill, gross, beginning balance Goodwill, gross, ending balance Goodwill, Gross Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Schedule of Derivative Instruments in Statement of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Award Type [Domain] Award Type [Domain] Weighted-average period over which total unrecognized compensation expense expected to be recognized, in years Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Average remaining contractual term for stock awards exercisable, in years Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Income Tax Contingency [Table] Income Tax Contingency [Table] Restructuring Plan [Domain] Restructuring Plan [Domain] Components of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Note Securitization Facility Note Securitization Facility [Member] Note Securitization Facility [Member] Restructuring Reserve, Settled without Cash Restructuring Reserve, Settled without Cash Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Derivative Contract Type [Domain] Derivative Contract [Domain] Australian Taxation Office Australian Taxation Office [Member] Net Investment Hedging Net Investment Hedging [Member] Gross profit Gross loss Gross Profit SeniorNotesTwoThousandTwentyEight [Member] SeniorNotesTwoThousandTwentyEight [Member] SeniorNotesTwoThousandTwentyEight [Member] Other Assets Schedule of Other Assets, Noncurrent [Table Text Block] Entity Registrant Name Entity Registrant Name Issuance of common stock (in shares) Stock Issued During Period, Shares, New Issues Net unrecognized gain on derivatives in cash flow hedging relationships, net of tax AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax Subsequent Events Subsequent Events [Text Block] Biocon Biologics Biocon Biologics [Member] Biocon Biologics Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Foreign Currency Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Patents and technologies Patents [Member] Influvac ® Influvac ® [Member] Influvac ® Entity Address, City or Town Entity Address, City or Town Pension and Other Postretirement Benefits Disclosure Retirement Benefits [Text Block] Operating expenses: Operating Expenses [Abstract] Total equity Balance Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Asset Class [Domain] Asset Class [Domain] Other revenues Revenue Not from Contract with Customer Minimum Minimum [Member] Restricted cash Restricted Cash and Cash Equivalents, Current Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common Stock, Par or Stated Value Per Share Ordinary shares, nominal value Common Stock, Par or Stated Value Per Share Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Raw materials Inventory, Raw Materials, Net of Reserves Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Investment, Name [Axis] Investment, Name [Axis] Trading Symbol Trading Symbol Entity File Number Entity File Number Balance Sheet Components [Abstract] Balance Sheet Components [Abstract] Balance Sheet Components Accounts payable Accounts payable Accounts Payable, Trade, Current Schedule of other current liabilities [Line Items] Schedule of other current liabilities [Line Items] [Line Items] for Schedule of other current liabilities [Table] Unusual or Infrequent Item, or Both Unusual or Infrequent Item, or Both [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Four Accrued interest Interest Payable, Current Research and development Research and development Research and Development Expense Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Proceeds from sale and collection of receivables Proceeds from Sale and Collection of Receivables Number of restricted stock awards, granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Restricted stock awards Restricted Stock Units (RSUs) [Member] Rebates, promotional programs and other sales allowances Accrued Sales Allowances Accrued Sales Allowances Accretion expense Accretion Expense 2020 Senior Notes (3.750% coupon) Senior Notes Two Thousand Twenty - 3.75 Percent [Member] Senior Notes Two Thousand Twenty - 3.75 Percent Vested and expected to vest at September 30, 2022 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Returns Revenue from Contract with Customer, Returns Revenue from Contract with Customer, Returns Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Percent ownership after transaction Disposal Group, Including Discontinued Operation, Consideration, Convertible Preferred Equity, Percent Ownership Disposal Group, Including Discontinued Operation, Consideration, Convertible Preferred Equity, Percent Ownership Mylan Mylan N.V. Parent Company [Member] 2027 Senior Notes 2027 Senior Notes [Member] 2027 Senior Notes 2024 Euro Senior Notes 2024 Euro Senior Notes [Member] 2024 Euro Senior Notes [Member] Equity Method Investments and Joint Ventures [Abstract] Equity Method Investments and Joint Ventures [Abstract] Subsequent Events [Abstract] Total revenues Revenues Revenues Income Taxes Income Tax Disclosure [Text Block] Revolving Facility Revolving Facility [Member] Revolving Facility Finished goods Inventory, Finished Goods, Net of Reserves Intangible asset amortization expense Amortization of Intangible Assets Amortization of Intangible Assets Intangible assets, gross, excluding goodwill Intangible Assets, Gross (Excluding Goodwill) Changes in Carrying Amount of Goodwill Schedule of Goodwill [Table Text Block] Basic (in USD per share) Basic earnings (loss) per share attributable to Viatris Inc. shareholders Earnings Per Share, Basic Term of transition services agreement Disposal Group, Including Discontinued Operations, Term Of Transition Services Agreement Disposal Group, Including Discontinued Operations, Term Of Transition Services Agreement Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Multi District Litigation [Member] Multi District Litigation [Member] Multi District Litigation [Member] Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities Corporate / Other Corporate, Non-Segment [Member] Defined Benefit Plan Items Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Cash dividends paid Payments to Noncontrolling Interests Land and improvements Land and Land Improvements [Member] Counterparty Name [Domain] Counterparty Name [Domain] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Treasury Stock Treasury Stock [Member] Prepaid expenses Prepaid Expense, Current Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Weighted average grant-date fair value per share, forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Corporate costs Corporate costs Corporate costs Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Entity Interactive Data Current Entity Interactive Data Current Finite-lived intangible assets, accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Issuance of restricted stock and stock options exercised, net Restricted Stock, Value, Shares Issued Net of Tax Withholdings Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Three 2026 Long-Term Debt, Maturity, Year Five Money market funds Money Market Funds [Member] Pension and other postretirement benefits Other Pension, Postretirement and Supplemental Plans [Member] Retained Earnings Retained Earnings [Member] Retained Earnings [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Cash dividends declared Dividends, Common Stock, Cash Litigation settlements and other contingencies, net Litigation settlements and other contingencies, net Gain (Loss) Related to Litigation Settlement Common Stock Marketable securities Common Stock [Member] Receivable Type [Axis] Receivable Type [Axis] 2024 Euro Senior Notes, 1.023% 2024 Euro Senior Notes, 1.023% [Member] 2024 Euro Senior Notes, 1.023% Contingent consideration Balance at beginning of period Balance at end of period Business Combination, Contingent Consideration, Liability Thereafter Long-Term Debt, Maturity, after Year Five Measurement Input, Reduction in Terminal Year Revenue Growth Rate Measurement Input, Reduction in Terminal Year Revenue Growth Rate [Member] Measurement Input, Reduction in Terminal Year Revenue Growth Rate Statement [Table] Statement [Table] Disposal Groups, Including Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Goodwill, Transfers Goodwill, Transfers Weighted average grant-date fair value per share, released Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Trade receivables, net Receivables, Net, Current Document Quarterly Report Document Quarterly Report Current assets: Assets, Current [Abstract] Operating Lease, Liability, Noncurrent Operating Lease, Liability, Noncurrent Restructuring and Related Cost, Expected Cost Remaining Restructuring and Related Cost, Expected Cost Remaining Proceeds from sale of terminated interest rate swaps Proceeds from Sale of Securities, Operating Activities 2046 Senior Notes (5.250% coupon) SeniorNotesTwoThousandFortySix5.25Precent [Member] 2046 Senior Note (5.250%) Range [Axis] Statistical Measurement [Axis] Non-contingent payments for product rights Payment for Contingent Consideration Liability, Financing Activities Other comprehensive loss, before tax Other comprehensive loss, before tax Other Comprehensive Income (Loss), before Tax Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] In-process research and development Indefinite-Lived Intangible Assets (Excluding Goodwill) Generics Generics [Member] Generics Retained earnings Retained Earnings (Accumulated Deficit) Disposal Group Name [Axis] Disposal Group Name [Axis] Recognized net actuarial losses Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Accounts receivable, net Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Purchase of marketable securities Payments to Acquire Marketable Securities Equity Components [Axis] Equity Components [Axis] Scenario, Unspecified [Domain] Scenario [Domain] Litigation Case Type [Domain] Litigation Case [Domain] Exercisable at September 30, 2022 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Segment Reporting Policy Segment Reporting, Policy [Policy Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Upfront payment subject to certain adjustments Disposal Group, Including Discontinued Operation, Cash Finite-lived Intangible Assets Amortization Expense Finite-Lived Intangible Assets Amortization Expense [Table Text Block] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Measurement Input, EBITDA Multiple Measurement Input, EBITDA Multiple [Member] 2028 Euro Senior Notes 2028 Euro Senior Notes [Member] 2028 Euro Senior Notes [Member] Number of restricted stock awards, nonvested beginning of period Number of restricted stock awards, nonvested end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Finite-lived intangible assets, original cost Finite-Lived Intangible Assets, Gross Selling, general and administrative Selling, General and Administrative Expense New Accounting Pronouncements Accounting Standards Update and Change in Accounting Principle [Text Block] Loss Contingencies [Table] Loss Contingencies [Table] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] AOCI Attributable to Parent [Member] Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Unusual Risk or Uncertainty [Line Items] Unusual Risk or Uncertainty [Line Items] Comprehensive Earnings Comprehensive Income (Loss) Note [Text Block] Creon ® Creon ® [Member] Creon ® Vested and expected to vest at September 30, 2022 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Type of Restructuring [Domain] Type of Restructuring [Domain] Document Transition Report Document Transition Report Foreign Tax Authority Foreign Tax Authority [Member] Local Phone Number Local Phone Number Stock Awards Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Earnings from operations Operating Income (Loss) Inventories Increase (Decrease) in Inventories Foreign currency translation Restructuring Reserve, Translation and Other Adjustment Current Portion of Long-Term Debt Current Portion of Long-Term Debt [Member] Number of states Number of states Number of states Goodwill Goodwill Goodwill, net, beginning balance Goodwill, net, ending balance Goodwill Other Current Liabilities Other current liabilities Other Current Liabilities [Member] Treasury stock, shares Balance (in shares) Balance (in shares) Treasury Stock, Shares Financial and Nonfinancial Liabilities, Fair Value Disclosure Liabilities, Fair Value Disclosure Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Amortization of actuarial loss included in SG&A Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax 2050 Senior Notes 2050 Senior Notes [Member] 2050 Senior Notes Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Oyster Point Pharma, Inc. Oyster Point Pharma, Inc. [Member] Oyster Point Pharma, Inc. Income tax provision (benefit) Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Deferred income tax liability Deferred Income Tax Liabilities, Net Income Statement [Abstract] Income Statement [Abstract] Hedging Relationship [Axis] Hedging Relationship [Axis] Additional Paid-In Capital Additional Paid-in Capital [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Document Fiscal Period Focus Document Fiscal Period Focus Cost of sales Cost of Goods and Services Sold Derivative [Line Items] Derivative [Line Items] Diluted (in shares) Total dilutive shares outstanding Weighted Average Number of Shares Outstanding, Diluted Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Inventories Schedule of Inventory, Current [Table Text Block] Anticompetitive Conduct with Generic Drugs [Member] Anticompetitive Conduct with Generic Drugs [Member] Anticompetitive Conduct with Generic Drugs [Member] Fair value of financial instruments Derivative Liability, Subject to Master Netting Arrangement, before Offset Loss Contingencies [Line Items] Loss Contingencies [Line Items] Developed Markets Developed Markets Segment [Member] Developed Markets Segment Other Other Long Term Debt [Member] Other long term debt. Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement Collaborative Arrangement [Member] Buildings and improvements Building and Building Improvements [Member] Dividends paid (in dollars per share) Common Stock, Dividends, Per Share, Cash Paid Celebrex ® Celebrex ® [Member] Celebrex ® 2028 Senior Notes [Member] 2028 Senior Notes [Member] 2028 Senior Notes [Member] [Member] Common stock: $0.01 par value, 3,000,000,000 shares authorized; shares issued and outstanding: 1,212,653,465 and 1,209,507,463, respectively Common Stock, Value, Issued Measurement Input, Long-term Revenue Growth Rate Measurement Input, Long-Term Revenue Growth Rate [Member] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Senior Notes Senior Notes [Member] Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Weighted average grant-date fair value per share, granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Short-term Debt [Line Items] Short-Term Debt [Line Items] Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Tax related items, including contingencies Liability for Uncertainty in Income Taxes, Noncurrent Financial Assets and Liabilities Carried at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Operating Segment Operating Segments [Member] Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Cash, cash equivalents and restricted cash — beginning of period Cash, cash equivalents and restricted cash — end of period Cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Litigation Commitments and Contingencies Disclosure [Text Block] Accumulated impairment losses, beginning balance Accumulated impairment losses, ending balance Goodwill, Impaired, Accumulated Impairment Loss Current liabilities: Liabilities, Current [Abstract] Foreign exchange forward contracts Foreign Exchange Forward [Member] Proceeds from issuance of long-term debt Proceeds from Issuance of Long-Term Debt Net earnings (loss) Net earnings (loss) attributable to Viatris Inc. common shareholders Net earnings (loss) Net Income (Loss) Available to Common Stockholders, Basic Equity Method Investments Equity Method Investments [Table Text Block] Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Average remaining contractual term for stock awards vested and expected to vest, in years Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Other Liabilities, Fair Value Disclosure Other Liabilities, Fair Value Disclosure Gains and Losses on Derivatives Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Lyrica ® Lyrica ® [Member] Lyrica ® Retirement Plan Type [Domain] Retirement Plan Type [Domain] Reclassification out of Accumulated Other Comprehensive Income [Member] Reclassification out of Accumulated Other Comprehensive Income [Member] Income Statement Location [Domain] Income Statement Location [Domain] Biosimilars Portfolio Biosimilars Portfolio [Member] Biosimilars Portfolio Cash Flow Hedging Cash Flow Hedging [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Amendment Flag Amendment Flag Finite-lived intangible assets, estimated useful life, in years Finite-Lived Intangible Asset, Useful Life Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities Other comprehensive loss, net of tax Other comprehensive loss, net of tax Other Comprehensive Income (Loss), Net of Tax Corporate and Other Corporate and Other [Member] Comprehensive (loss) earnings Comprehensive Income (Loss), Net of Tax, Attributable to Parent Litigation Case [Axis] Litigation Case [Axis] Restructuring Restructuring Reserve, Current Reconciliation of Segment Information to Total Consolidated Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Construction in progress Construction in Progress [Member] Contingent consideration payments Payments of Merger Related Costs, Financing Activities Entity Current Reporting Status Entity Current Reporting Status Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Other current liabilities Equity method investments, clean energy investments Other Liabilities, Current Other assets Other assets Other Assets, Noncurrent Cash payment Payments for Restructuring Exercisable at September 30, 2022 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Zoloft ® Zoloft ® [Member] Zoloft ® Depreciation and amortization Depreciation, Depletion and Amortization 2040 Senior Notes 2040 Senior Notes [Member] 2040 Senior Notes Foreign currency translation Goodwill, Translation and Purchase Accounting Adjustments Measurement Input, Control Premium Measurement Input, Control Premium [Member] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Prepaid expenses and other current assets Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current Employee Related Costs Employee Severance [Member] YEN Term Loan YEN Term Loan [Member] YEN Term Loan Dividends payable (in dollars per share) Dividends Payable, Amount Per Share Counterparty Name [Axis] Counterparty Name [Axis] 2025 Senior Notes 2025 Senior Notes [Member] 2025 Senior Notes Derivative [Table] Derivative [Table] Chargebacks Chargebacks Chargebacks Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding at December 31, 2021 Outstanding at September 30, 2022 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Legal and professional accruals, including litigation accruals Estimated Litigation Liability, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Other assets Disposal Group, Including Discontinued Operation, Other Assets Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Basis of Accounting Policy Basis of Accounting, Policy [Policy Text Block] Effect on cash of changes in exchange rates Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Liabilities Liabilities [Abstract] Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] Payments of long-term debt Repayments of Long-Term Debt Expected Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Stock awards Share-Based Payment Arrangement, Option [Member] Program Name [Domain] Program Name [Domain] [Domain] for Program Name Long-term debt Long-Term Debt Number of restricted stock awards, forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Other (income) expense, net Other Nonoperating Income (Expense) Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Axis] EpiPen Auto-Injector Litigation EpiPen Auto-Injector Litigation [Member] EpiPen Auto-Injector Litigation Restructuring Restructuring and Related Activities Disclosure [Text Block] Ordinary shares, shares authorized Common Stock, Shares Authorized Business Combination, Separately Recognized Transactions [Table] Business Combination, Separately Recognized Transactions [Table] Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Income taxes payable Accrued Income Taxes, Current Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Total operating expenses Operating Expenses Maximum Maximum [Member] Accumulated other comprehensive loss Accumulated other comprehensive loss: Accumulated Other Comprehensive Income (Loss), Net of Tax Accounts payable Increase (Decrease) in Accounts Payable, Trade Fair value loss Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss) Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss) Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Total current assets Assets, Current Designated as Hedging Instrument Designated as Hedging Instrument [Member] Other long-term assets Other long-term assets Other long-term assets Payments for Legal Settlements Payments for Legal Settlements Litigation settlements and other contingencies, net Change in noncash litigation settlements, net Change in noncash litigation settlements, net Entity Small Business Entity Small Business Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Dividends declared (in dollars per share) Common Stock, Dividends, Per Share, Declared Revenues [Abstract] Revenues [Abstract] Finite-lived intangible assets, net book value Finite-Lived Intangible Assets, Net 2023 Senior Notes (4.200% coupon) SeniorNotesTwoThousandTwentyThree4.2Percent [Member] Senior notes two thousand twenty three - 4.2 percent Unusual or Infrequent Item, or Both [Domain] Unusual or Infrequent Item, or Both [Domain] Total unrecognized compensation expense, net of estimated forfeitures Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Notional amount of derivative Derivative Asset, Notional Amount Number of Shares Under Stock Awards Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Sales Revenue, Gross to net adjustments Sales Revenue, Gross to net adjustments Sales Revenue, Gross to net adjustments Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Xanax ® Xanax ® [Member] Xanax ® Other Noncurrent Liabilities Other Noncurrent Liabilities [Table Text Block] Accounts receivable Increase (Decrease) in Accounts Receivable Short-term borrowings Short-Term Debt Title of 12(b) Security Title of 12(b) Security Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] General Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Consolidated Entities [Axis] Consolidated Entities [Axis] Other Liabilities, Other than Long-Term Debt, Noncurrent Other Revenues Product and Service, Other [Member] Contingent consideration Contingent Consideration [Member] Contingent Consideration. Debt Instrument [Line Items] Debt Instrument [Line Items] Reporting Unit [Axis] Reporting Unit [Axis] Intrinsic value of stock-based awards exercised and restricted stock units converted Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Variable Consideration Variable Consideration [Member] Variable Consideration [Member] 2030 Senior Notes 2030 Senior Notes [Member] 2030 Senior Notes Segment Information Segment Reporting Disclosure [Text Block] Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Two LIABILITIES AND EQUITY Liabilities and Equity [Abstract] 2027 Euro Senior Notes 2027 Euro Senior Notes [Member] 2027 Euro Senior Notes U.S. Treasuries US Treasury Securities [Member] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Weighted average shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Accounts payable Disposal Group, Including Discontinued Operation, Other Liabilities, Current Other expense Other Expense [Member] Inventories Inventories Inventory, Net Charges Restructuring Charges Income Tax Authority [Axis] Income Tax Authority [Axis] Schedule of Other Noncurrent Liabilities [Line Items] Schedule of Other Noncurrent Liabilities [Line Items] [Line Items] for Schedule of Other Noncurrent Liabilities [Table] 2025 Long-Term Debt, Maturity, Year Four Hedging Relationship [Domain] Hedging Relationship [Domain] Hedging Designation [Axis] Hedging Designation [Axis] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Proceeds from sale of assets and subsidiaries Proceeds from Sales of Business, Affiliate and Productive Assets Employee benefit liabilities Liability, Defined Benefit Pension Plan, Noncurrent Entity Filer Category Entity Filer Category Issuance of common stock Proceeds from Issuance of Common Stock Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Basic (in shares) Weighted average shares outstanding Weighted Average Number of Shares Outstanding, Basic Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Loss Contingency Accrual Loss Contingency Accrual Other payables Accounts Payable, Other Unusual Risk or Uncertainty [Table] Unusual Risk or Uncertainty [Table] Complex GX and Biosimilars Complex GX and Biosimilars [Member] Complex GX and Biosimilars Amitiza ® Amitiza ® [Member] Amitiza ® Security Exchange Name Security Exchange Name Outstanding at December 31, 2021 Outstanding at September 30, 2022 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Emerging Markets Emerging Markets Segment [Member] Emerging Markets Segment Greater China Greater China Segment [Member] Greater China Segment Receivables Facility Receivables Facility [Member] Receivables facility. Medicaid and other governmental rebates Medicaid and other governmental rebates Medicaid and other governmental rebates Reconciling items: Segment Reconciling Items [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Summary of Long-Term Debt Schedule of Debt [Table Text Block] Short-term Debt, Type [Domain] Short-Term Debt, Type [Domain] Net sales Sales Revenue, Goods, Net Revenue from Contract with Customer, Excluding Assessed Tax Corporate bonds Corporate Bond Securities [Member] Income taxes Increase (Decrease) in Income Taxes Payable Service cost Defined Benefit Plan, Service Cost Damages to be paid Loss Contingency, Damages Paid, Value Development and sales milestone payments Development and sales milestone payments Development and sales milestone payments Current portion of long-term debt Debt, Current Common Stock, Capital Shares Reserved for Future Issuance Common Stock, Capital Shares Reserved for Future Issuance Cover [Abstract] Cover [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] TURKEY TURKEY Level 3 Fair Value, Inputs, Level 3 [Member] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Share-Based Incentive Plan Share-Based Payment Arrangement [Text Block] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Work in process Inventory, Work in Process, Net of Reserves Revenue Recognition and Accounts Receivable Revenue from Contract with Customer [Text Block] Equity method investments summarized financial data basis Equity Method Investments Summarized Financial Data Basis Equity Method Investments Summarized Financial Data Basis Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Segment Reporting [Abstract] Segment Reporting [Abstract] Utilization Restructuring and Related Cost, Incurred Cost Scenario, Forecast Forecast [Member] Taxes paid related to net share settlement of equity awards Payment, Tax Withholding, Share-Based Payment Arrangement Total liabilities and equity Liabilities and Equity Type of Arrangement and Non-arrangement Transactions [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Intangible Assets by Major Class [Line Items] Intangible Assets by Major Class [Line Items] Intangible Assets by Major Class Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] 2022 Euro Senior Notes 2022 Euro Senior Notes [Member] 2022 Euro Senior Notes Goodwill [Roll Forward] Goodwill [Roll Forward] Oyster Point Pharma, Inc. and Famy Life Sciences Private Limited Oyster Point Pharma, Inc. and Famy Life Sciences Private Limited [Member] Oyster Point Pharma, Inc. and Famy Life Sciences Private Limited Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Lipitor Lipitor ® [Member] Lipitor ® Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Not Designated as Hedging Instruments Not Designated as Hedging Instrument [Member] Disposal Group Name [Domain] Disposal Group Name [Domain] Cash flows from investing activities: Payments to Acquire Businesses, Net of Cash Acquired Level 2 Fair Value, Inputs, Level 2 [Member] Current Fiscal Year End Date Current Fiscal Year End Date Reserve for Uncertain Tax Positions, Including Interest And Penalties Reserve for Uncertain Tax Positions, Including Interest And Penalties Reserve for Uncertain Tax Positions, Including Interest And Penalties Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Intangible assets, net Intangible assets, net book value, excluding goodwill Intangible Assets, Net (Excluding Goodwill) Assets held for sale Disposal Group, Including Discontinued Operation, Assets Diluted (in USD per share) Diluted earnings (loss) per ordinary share Earnings Per Share, Diluted Proceeds from sale of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Net unrealized loss on marketable securities Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, before Tax, Portion Attributable to Parent Other Litigation Other [Member] Stock option award vesting period, in years Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Net unrecognized gain on derivatives in cash flow hedging relationships, net of tax Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Consolidation Items [Axis] Consolidation Items [Axis] Total current liabilities Liabilities, Current Reporting Unit [Domain] Reporting Unit [Domain] Brands Brands [Member] Brands Other Exit Costs Other Restructuring [Member] Other current assets Other Assets, Current Schedule of Accounts Receivable, Net Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Dymista ® Dymista ® [Member] Dymista ® Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Defined benefit plans, estimated benefit payments, in current fiscal year Defined benefit plans, estimated benefit payments, in current fiscal year Defined benefit plans, estimated benefit payments, in current fiscal year Stock option award expiration period, in years Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Other comprehensive earnings (loss) before reclassifications, before tax Other Comprehensive Income (Loss), before Reclassifications, before Tax Total intangible asset amortization expense (including impairment charges) Amortization Fair value of financial instruments Derivative Asset, Subject to Master Netting Arrangement, before Offset Accounts receivable, net Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Entity Address, Address Line One Entity Address, Address Line One Income tax provision Other Comprehensive Income (Loss), Tax Income Tax Authority [Domain] Income Tax Authority [Domain] Business Combination Contingent Consideration Liability Payments Payments Business Combination Contingent Consideration Liability Payments Business Combination Contingent Consideration Liability Payments Other items, net Proceeds from (Payments for) Other Financing Activities Other Assets, Noncurrent [Abstract] Other Assets, Noncurrent [Abstract] Amended Anticompetitive Conduct with Generic Drugs [Member] Amended Anticompetitive Conduct with Generic Drugs [Member] Amended Anticompetitive Conduct with Generic Drugs [Member] Intangible asset impairment charges Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) Product and Service [Axis] Product and Service [Axis] Change in short-term borrowings, net Proceeds from (Repayments of) Short-Term Debt Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Interest expense Interest Expense Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Accounts payable Disposal Group, Including Discontinued Operation, Accounts Payable Retirement Plan Type [Axis] Retirement Plan Type [Axis] Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Goodwill Impairment, Measurement Input Goodwill Impairment, Measurement Input Goodwill Impairment, Measurement Input Equity [Abstract] Equity [Abstract] Machinery and equipment Machinery and Equipment [Member] Product Liability Product Liability [Member] Product Liability Number of restricted stock awards, released Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Other receivables Other Receivables, Net, Current Issuance of restricted stock, net of shares withheld (in shares) Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Entity Tax Identification Number Entity Tax Identification Number Unamortized debt issuance expense Unamortized Debt Issuance Expense Ordinary shares reserved for issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Foreign exchange derivative assets Foreign Currency Contract, Asset, Fair Value Disclosure Schedule of Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Greater China Europe Segment [Member] Europe Segment Business Combination, Separately Recognized Transactions [Line Items] Business Combination, Separately Recognized Transactions [Line Items] Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Schedule of Short-term Debt [Table] Schedule of Short-Term Debt [Table] Effexor ® Effexor ® [Member] Effexor ® Exchange traded funds Exchange Traded Funds [Member] Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] 2022 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Consolidated Entities [Domain] Consolidated Entities [Domain] Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration] Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration] Norvasc Norvasc ® [Member] Norvasc ® Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Restructuring - employee related Restructuring and Related Costs [Table Text Block] Business Combination, Contingent Consideration, Liability, Measurement Input Business Combination, Contingent Consideration, Liability, Measurement Input Commercial Paper [Member] Commercial Paper [Member] Long-Term Incentive Plan 2003 Long Term Incentive Plan 2003 [Member] Long-Term Incentive 2003 Plan. Entity Central Index Key Entity Central Index Key Gross sales Revenue from Contract with Customer, Gross Revenue from Contract with Customer, Gross Percent Of Net Sales Impacted, High Inflationary Economy Percent Of Consolidated Net Sales Impacted, High Inflationary Economy Percent Of Consolidated Net Sales Impacted, High Inflationary Economy Business Acquisition, Non-Transferable Contingent Value Right, Number Of Rights Per Share Business Acquisition, Non-Transferable Contingent Value Right, Number Of Rights Business Acquisition, Non-Transferable Contingent Value Right, Number Of Rights Other comprehensive loss, before tax: Other Comprehensive Income (Loss), before Tax [Abstract] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Taxes related to the net share settlement of equity awards Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Collaboration and Licensing Agreements Collaborative Arrangement Disclosure [Text Block] Components of Other Comprehensive Loss Comprehensive Income (Loss) [Table Text Block] Other Other Accrued Liabilities, Current Measurement Input Type [Axis] Measurement Input Type [Axis] Estimated litigation liability Estimated Litigation Liability Entity [Domain] Entity [Domain] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] City Area Code City Area Code ASSETS Assets [Abstract] Good will, After Amortization Expense, Before Reclassification Good will, After Amortization Expense, Before Reclassification Good will, After Amortization Expense, Before Reclassification Other operating assets and liabilities, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Other Other Debt Obligations [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Agency mortgage-backed securities Collateralized Mortgage-Backed Securities [Member] Short-term Debt [Abstract] Short-Term Debt [Abstract] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Measurement Input, Increase in Discount Rate Measurement Input, Increase in Discount Rate [Member] Measurement Input, Increase in Discount Rate Asset Class [Axis] Asset Class [Axis] Earnings per Share Policy Earnings Per Share, Policy [Policy Text Block] 2022 Long-Term Debt, Maturity, Year One Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Net unrecognized gain on derivatives in net investment hedging relationships Net unrecognized gain (loss) on derivatives Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, before Tax, Parent Other long-term obligations Other Liabilities, Noncurrent Equity Method Investments Equity Method Investments and Joint Ventures Disclosure [Text Block] Loss from equity method investments Income (Loss) from Equity Method Investments Disposal Group Classification [Domain] Disposal Group Classification [Domain] Capital expenditures Payments to Acquire Property, Plant, and Equipment Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] 2023 Finite-Lived Intangible Asset, Expected Amortization, Year One Basic and Diluted Earnings per Ordinary Share Attributable to Mylan N.V. Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Other One-Time Nonoperating Expense Other One-Time Nonoperating Expense Other One-Time Nonoperating Expense 2048 Senior Notes 2048 Senior Notes [Member] 2048 Senior Notes [Member]